I Ching Wu

No open positions remaining

Health Technology

Consumer Services

Profile

I Ching Wu formerly worked at Tanvex BioPharma, Inc., as Head-Finance & Accounting Department from 2014 to 2018, Tanvex BioPharma USA, Inc., as Chief of Finance, and Designerx Pharmaceuticals, Inc., as Chief of Finance.
Mr. Wu received his graduate degree from Baruch College.

Former positions of I Ching Wu

Companies	Position	End
TANVEX BIOPHARMA, INC.	Director of Finance/CFO	01/11/2018
Designerx Pharmaceuticals, Inc. Designerx Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Part of Polaris Group, Designerx Pharmaceuticals, Inc. is a multinational biotechnology company that specializes in the development of novel anti-cancer therapies. The company is based in Vacaville, CA. The company's lead drug candidate, Pegargiminase (Adi-Peg 20), is a biologic in late-stage clinical development for a variety of cancers. The CEO of the company is Po Wen Wu.	Director of Finance/CFO	-
Tanvex BioPharma USA, Inc. Tanvex BioPharma USA, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company	Director of Finance/CFO	-

See the detail of I Ching Wu's experience

Training of I Ching Wu

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of I Ching Wu's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Baruch College Baruch College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Tanvex BioPharma, Inc. Tanvex BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures biosimilar medicines to treat neutropenia, breast cancer and metastatic colorectal cancer	Health Technology
Tanvex BioPharma USA, Inc. Tanvex BioPharma USA, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company	Health Technology
Designerx Pharmaceuticals, Inc. Designerx Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Part of Polaris Group, Designerx Pharmaceuticals, Inc. is a multinational biotechnology company that specializes in the development of novel anti-cancer therapies. The company is based in Vacaville, CA. The company's lead drug candidate, Pegargiminase (Adi-Peg 20), is a biologic in late-stage clinical development for a variety of cancers. The CEO of the company is Po Wen Wu.	Health Technology

See company connections